Study of photodynamic treatment for P-388 lympho-leukemia in mice

Data are presented on the results of photodynamic treatment (PDT) of mice DBA2 with transplantable lympho-leukemia P-388. Different regimens of photosensitizer Dimegin and emission were used. Both intravenous PDT and in combination with local PDT should be recommended.

Saved in:
Bibliographic Details
Published inVoprosy onkologij Vol. 57; no. 1; p. 75
Main Authors Lagoda, T S, Kaplan, M A, Bondar', A M, Ponomarev, G V, Zubov, B V, Nikitin, A P, Egorova, S V, Ivanov, E A, Glushkova, A F, Kirichenko, A V, Iskra, E V, Lepekhin, N P, Brovin, A I, Spichenkova, O N
Format Journal Article
LanguageRussian
Published Russia (Federation) 2011
Subjects
Animals
Deuteroporphyrins - therapeutic use
Leukemia, Experimental - drug therapy
Lymphoma - drug therapy
Mice
Mice, Inbred DBA
Neoplasms, Experimental - drug therapy
Photochemotherapy - instrumentation
Photochemotherapy - methods
Photosensitizing Agents - therapeutic use
Transplantation, Heterologous
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:Data are presented on the results of photodynamic treatment (PDT) of mice DBA2 with transplantable lympho-leukemia P-388. Different regimens of photosensitizer Dimegin and emission were used. Both intravenous PDT and in combination with local PDT should be recommended.
ISSN:0507-3758